Psychedelic-Assisted Group Therapy: A Systematic Review
Alexander Trope, B. Anderson, Andrew R. Hooker, Giancarlo Glick, Christopher S. Stauffer, Joshua Woolley
Journal of Psychoactive Drugs March 15, 2019 DOI: 10.1080/02791072.2019.1593559 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Topics | LSD Psilocybin Psychedelic-assisted therapy |
| Keywords | Psychotherapist Modalities Group psychotherapy Clinical psychology Hallucinogen |
| Citations | 113 |
| Key findings | No prior review had systematically identified experimental studies of psychedelic-assisted group therapy, and this review characterizes those studies by clinical approach, method, and outcomes to stimulate future research. |
Abstract
Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation. Several recent reviews that highlight the contributions of this early literature have focused on psychedelic-assisted individual psychotherapy modalities. None have attempted to systematically identify and compile experimental studies of psychedelic-assisted group therapy. In therapeutic settings, psychedelics were often used to enhance group therapy for a variety of populations and clinical indications. We report on the results of a systematic review of the published literature in English and Spanish on psychedelic-assisted group therapies. Publications are characterized by their clinical approach, experimental method, and clinical outcomes. Given the renewed interest in the clinical use of psychedelic medicines, this review aims to stimulate hypotheses to be tested in future research on psychedelic-assisted psychotherapy, group process, and interpersonal functioning.
Comparable studies
Other systematic reviews and meta-analyses on LSD, most cited first.
Citations in the library
Cited by 95
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study EClinicalMedicine September 24, 2020
- Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Frontiers in Pharmacology March 25, 2021
- Psychedelics and Other Psychoplastogens for Treating Mental Illness Frontiers in Psychiatry October 4, 2021
- Psychedelic integration: An analysis of the concept and its practice Frontiers in Psychology August 4, 2022
- A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats Psychopharmacology March 10, 2021
and 90 more in the library
Cites 15
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Journal of Humanistic Psychology June 19, 2017
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors Journal of Psychopharmacology October 11, 2017
- Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology December 25, 2017
and 10 more in the library